Literature DB >> 8282091

Phospholipases and activation of the NADPH oxidase.

L C McPhail1, D Qualliotine-Mann, D E Agwu, C E McCall.   

Abstract

The signal transductional mechanisms regulating the activation of NADPH oxidase, the respiratory burst enzyme in phagocytic cells, are not completely understood. Receptors for most physiologic stimuli trigger the activation of various phospholipases, including phospholipases A2, C, and D. The lipid mediators formed (arachidonic acid, 1,2-diacylglycerol, and phosphatidic acid) have been implicated as second messengers in the induction of the respiratory burst. In intact cells, we have correlated phospholipase D activation and the production of phosphatidic acid with the activation of NADPH oxidase, using the drug propranolol. Phosphatidic acid activated NADPH oxidase in a cell-free system, but the level of activation was low. 1,2-Diacylglycerol markedly enhanced NADPH oxidase activation by phosphatidic acid. The synergistic effect required the diacyl species, since mono- or tri-acylglycerols were ineffective. Phosphatidic acid could be replaced by either lysophosphatidic acid or phosphatidylserine, but not by phosphatidylcholine, phosphatidylethanolamine, or phosphatidylinositol, suggesting specificity for an anionic phospholipid. Since other cell-free activators of NADPH oxidase (arachidonic acid, sodium dodecyl sulfate) are also anionic amphiphiles, phosphatidic acid may directly interact with an enzyme component(s). The targets for phosphatidic acid and diacylglycerol in the cell-free system are currently under investigation. These results emphasize the critical importance of phospholipases, particularly phospholipase D, in the regulation of the respiratory burst.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282091     DOI: 10.1111/j.1600-0609.1993.tb01611.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox.

Authors:  J Shi; C R Ross; T L Leto; F Blecha
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Changes of fatty acid composition and oxidative metabolism of human neutrophils migrating into an inflammatory exudate.

Authors:  A Carletto; P Bellavite; P Guarini; D Biasi; S Chirumbolo; P Caramaschi; L M Bambara; R Corrocher
Journal:  Inflammation       Date:  1996-04       Impact factor: 4.092

Review 3.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  Cell-free activation of neutrophil NADPH oxidase by a phosphatidic acid-regulated protein kinase.

Authors:  L C McPhail; D Qualliotine-Mann; K A Waite
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 5.  Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins.

Authors:  Srikanth Pendyala; Peter V Usatyuk; Irina A Gorshkova; Joe G N Garcia; Viswanathan Natarajan
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

6.  Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding.

Authors:  Eric M Lewis; Susan Sergeant; Bill Ledford; Natalie Stull; Mary C Dinauer; Linda C McPhail
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

Review 7.  SH3-dependent assembly of the phagocyte NADPH oxidase.

Authors:  L C McPhail
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

8.  Annexin peptide Ac2-26 suppresses TNFα-induced inflammatory responses via inhibition of Rac1-dependent NADPH oxidase in human endothelial cells.

Authors:  Hitesh M Peshavariya; Caroline J Taylor; Celeste Goh; Guei-Sheung Liu; Fan Jiang; Elsa C Chan; Gregory J Dusting
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.